Acquisitions, Sale of Hospira Infusion Systems Net Assets, Collaborative Arrangement, Equity-Method Investments and Cost-Method Investment - Collaboration Arrangement (Details) - Other (Income)/Deductions, Net [Member] - Merck KGaA [Member] - Collaborative Arrangement [Member] $ in Millions	3 Months Ended
	Apr. 02, 2017 USD ($)
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]
Upfront payments received	$ 90
Collaborator's revenue and expense ownership percentage	60.00%
Company's revenue and expense ownership percentage	40.00%